J0179
HCPCSInj, brolucizumab-dbll, 1 mg
Official HCPCS Level II long descriptor
Injection, brolucizumab-dbll, 1 mg
HCPCS Level II code J0179 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, brolucizumab-dbll, 1 mg
Added to HCPCS: 2020-01-01
Nearby codes in J0
- J0166Inj epinephrine (bpi)
- J0167Inj epinephrine (hospira)
- J0168Epinephrine (intl med sys)
- J0169Inj epinephrine (adrenalin)
- J0174Lecanemab-irmb, for iv inj
- J0175Inj, donanemab-azbt, 2 mg
- J0177Inj, aflibercept hd, 1 mg
- J0178Aflibercept injection
- J0180Agalsidase beta injection
- J0184Inj, amisulpride, 1 mg
- J0185Inj., aprepitant, 1 mg
- J0202Injection, alemtuzumab
- J0206Inj allopurinol sodium 1 mg
- J0207Amifostine
- J0208Inj, pedmark, 100 mg
- J0209Inj, sod thiosulfate (hope)
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.